An ImmunoModulatory and Myotrophic Formulation with Simultaneous Neurotrophic Properties for The Treatment of ALS and Multiple Sclerosis IMMUNOMODULATION SARM

Name: An ImmunoModulatory and Myotrophic Formulation with Simultaneous Neurotrophic Properties for The Treatment of ALS and Multiple Sclerosis
Creator: Spektral Holding BV
License: https://creativecommons.org/licenses/by/4.0/
Keywords: als,health,immunomodulation,multiple-sclerosis,myotrophic,neuromascular-efficiency,sante,sarm

Updated on September 1, 2021 — Creative Commons Attribution 4.0

Spektral Holding BV

Spektral Holding BV is an Investment Holding company based in Amsterdam. Spektral Holding is the sole shareholder of Mas Pharmaceutical Investment Corp. , Mas Intermediary Chemicals & Pharmaceuticals Corp, Tekas Investment Corp. Company holds the royalty rights of 80 Mining Licenses in Turkey.…

1 datasets

Informations

License: Creative Commons Attribution 4.0
ID: 5ea13ab9f176a10bfcd9d7f0

Temporality

Frequency: Annual
Creation date: April 23, 2020
Latest resource update: April 23, 2020

Participate

Add a reuse Contact the producer

Embed

<div data-udata-dataset="5ea13ab9f176a10bfcd9d7f0"></div><script  src="https://data.public.lu/static/oembed.js" async defer></script>

Permalink

Description

An Immunomodulatory Formulation consisting of Nf-Kappa B , TNF-A and IL-6 Suppressive Protopanaxatriol Class Glucopyranoside Analouges, A Neurotrophic Protobioside Analouge that Promotes Myelin Regeneration , A Myotrophic Bioceutical Extract with Partial SARM-Like Effects thus increasing Muscle Mass via Protein Synthesis Enhancement , via GDF-8 Suppression, increasing intramascular MGF and IGF-1 mRNA Expression and Enhancing Cholinergic Neuromascular Transmission Duration. By Inhibiting Pro-Inflammatory Cytokine Release and via increasing Selective Anabolism Formulation Serves as an Effective Adjunctive Treatment for ALS and Multiple Sclerosis.

Inventors : Erdal Can ALKOCLAR

Metehan YESIl

Files ²

Main file

201305306.pdf

Updated on April 23, 2020 — pdf (142.1Ko) — 1 downloads

Novelty Report & Scientific Research Abstracts

URL: https://download.data.public.lu/resources/an-immunomodulatory-and-myotrophic-formulation-with-simultaneous-neurotrophic-properties-for-the-treatment-of-als-and-multiple-sclerosis/20200423-085631/201305306.pdf
Permalink: https://data.public.lu/en/datasets/r/2e6fed36-7a93-498f-8ff6-507e9a6fac3c
Type: Main file
MIME Type: application/pdf
sha1: 759329894c5568dae167966792640ce9d27bfe2b
Created on: April 23, 2020
Modified on: April 23, 2020
Published on: April 23, 2020

16-ms-ve-als.docx

Updated on April 23, 2020 — docx (24.5Ko) — 1 downloads

Patent Content & Mechanism of Action and Compound Description

URL: https://download.data.public.lu/resources/an-immunomodulatory-and-myotrophic-formulation-with-simultaneous-neurotrophic-properties-for-the-treatment-of-als-and-multiple-sclerosis/20200423-085104/16-ms-ve-als.docx
Permalink: https://data.public.lu/en/datasets/r/cb1dba7c-968d-4dd3-acac-c979cd510c58
Type: Main file
MIME Type: application/vnd.openxmlformats-officedocument.wordprocessingml.document
sha1: d07f78bd5d7d2dea0965be50735dad003a2a3820
Created on: April 23, 2020
Modified on: April 23, 2020
Published on: April 23, 2020

Community resources ⁰

Publish a resource

You have built a more comprehensive database than those presented here? This is the time to share it!

Reuses ⁰

Add a reuse

Explore the reuses of this dataset.

Did you use this data ? Reference your work and increase your visibility.

Discussion between the organization and the community about this dataset.